Navigation Links
Dartmouth receives $2 million grant for children's health research center
Date:12/6/2010

Dartmouth recently received a $2 million pilot grant to fund the new Children's Environmental Health and Disease Prevention Center at Dartmouth. The grant is jointly funded by the United States Environmental Protection Agency (EPA) and the National Institute for Environmental Health Sciences (NIEHS). Dartmouth's is one of six emerging centers nationally that are undertaking interdisciplinary research to assist public health professionals and policy makers in combating children's diseases caused by environment pollutants.

Provost Carol Folt (left) and Professor Margaret Karagas are associate director and director, respectively, of the new Children's Environmental Health and Disease Prevention Center at Dartmouth. The center will advance understanding of how arsenic exposureeven at low levelsaffects the health of mothers and children. (photo by Joseph Mehling '69)

"Our nascent center will help advance our research on understanding the possible consequences of arsenic exposure on maternal and child health," says Margaret Karagas, the center's director and a professor of community and family medicine in epidemiology at Dartmouth Medical School (DMS). "In particular, it will allow us to gain critical insights on the effects of arsenic exposure on fetal growth and development as well as a mother's and infant's susceptibility to infection."

Populations around the world whose drinking water is highly contaminated with arsenic show increased incidences of low birth weight, fetal losses, cancer, and cardiovascular disease, says Karagas. However, she points out, "We don't yet know what levels of arsenic are safe. In our studies of cancer risks in New Hampshire, we've seen evidence that relatively low levels of exposure may have adverse health effects."

The fetal and neonatal period represent an especially vulnerable window of exposure, and there is a growing awareness that exposures early in life can influence children's health as well as the risk of adult onset diseases. "In rural areas such ours, we are concerned about people who rely on unregulated private water supplies for their homes," Karagas adds. "They may not be aware of the need to test their water for arsenic and other contaminants."

"Our new center brings together a diverse group of outstanding investigators, drawing on Dartmouth's strength in research and ease of bridging disciplines, departments, and schools," says Provost Carol Folt, associate director of the center and the Dartmouth Professor of Biological Sciences. "The reviewers also praised the center for bringing new scientists into this critical public health research area and pairing them with established mentors to ensure their success."

The center builds on the work of Dartmouth's highly interdisciplinary Toxic Metals Research group, which conducts leading research on toxic metals, including arsenic and mercury. Since its formation in 1995, the group has received research grants totaling over $40 million from the NIEHS's Superfund Research Program.


'/>"/>

Contact: Latarsha Gatlin
latarsha.r.gatlin@dartmouth.edu
603-646-3661
Dartmouth College
Source:Eurekalert

Related medicine news :

1. Dartmouth study uses the patients tumor to form vaccine
2. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
3. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
4. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
5. BestMassage.com Receives Award for Customer Trust
6. Corporate Wellness Firm Limeade Receives SAS 70 Type II Report
7. Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award
8. Special Olympics Georgia Receives Grant from The Home Depot Foundation
9. NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter
10. WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility
11. Verdan Receives Patent on Crystal Deodorant Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: